Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons

被引:65
作者
Goffredo, D
Rigamonti, D
Tartari, M
De Micheli, A
Verderio, C
Matteoli, M
Zuccato, C
Cattaneo, E
机构
[1] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy
[2] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy
[3] Univ Milan, Dept Med Pharmacol, Inst Neurosci, Natl Res Council, I-20133 Milan, Italy
关键词
D O I
10.1074/jbc.C200353200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is caused by a polyglutamine expansion in the amino-terminal region of huntingtin. Mutant huntingtin is proteolytically cleaved by caspases, generating amino-terminal aggregates that are toxic for cells. The addition of calpains to total brain homogenates also leads to cleavage of wild-type huntingtin, indicating that proteolysis of mutant and wildtype huntingtin may play a role in HD. Here we report that endogenous wild-type huntingtin is promptly cleaved by calpains in primary neurons. Exposure of primary neurons to glutamate or 3-nitropropionic acid increases intracellular calcium concentration, leading to loss of intact full-length wild-type huntingtin. This cleavage could be prevented by calcium chelators and calpain inhibitors. Degradation of wild-type huntingtin by calcium-dependent proteases thus occurs in HD neurons, leading to loss of wild-type huntingtin neuroprotective activity.
引用
收藏
页码:39594 / 39598
页数:5
相关论文
共 32 条
[1]   SUBSETS OF GABAERGIC NEURONS IN DISSOCIATED CELL-CULTURES OF NEONATAL RAT CEREBRAL-CORTEX SHOW CO-LOCALIZATION WITH SPECIFIC MODULATOR PEPTIDES [J].
ALHO, H ;
FERRARESE, C ;
VICINI, S ;
VACCARINO, F .
DEVELOPMENTAL BRAIN RESEARCH, 1988, 39 (02) :193-204
[2]   Loss of normal huntingtin function: new developments in Huntington's disease research [J].
Cattaneo, E ;
Rigamonti, D ;
Goffredo, D ;
Zuccato, C ;
Squitieri, F ;
Sipione, S .
TRENDS IN NEUROSCIENCES, 2001, 24 (03) :182-188
[3]   NMDA receptor function in mouse models of Huntington disease [J].
Cepeda, C ;
Ariano, MA ;
Calvert, CR ;
Flores-Hernández, J ;
Chandler, SH ;
Leavitt, BR ;
Hayden, MR ;
Levine, MS .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 66 (04) :525-539
[4]  
Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO
[5]  
2-B
[6]   Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease [J].
Chen, M ;
Ona, VO ;
Li, MW ;
Ferrante, RJ ;
Fink, KB ;
Zhu, S ;
Bian, J ;
Guo, L ;
Farrell, LA ;
Hersch, SM ;
Hobbs, W ;
Vonsattel, JP ;
Cha, JHJ ;
Friedlander, RM .
NATURE MEDICINE, 2000, 6 (07) :797-+
[7]   Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain [J].
DiFiglia, M ;
Sapp, E ;
Chase, KO ;
Davies, SW ;
Bates, GP ;
Vonsattel, JP ;
Aronin, N .
SCIENCE, 1997, 277 (5334) :1990-1993
[8]   Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice [J].
Dragatsis, I ;
Levine, MS ;
Zeitlin, S .
NATURE GENETICS, 2000, 26 (03) :300-306
[9]  
FERRANTE RJ, 1991, J NEUROSCI, V11, P3877
[10]   Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partners Hippi [J].
Gervais, FG ;
Singaraja, R ;
Xanthoudakis, S ;
Gutekunst, CA ;
Leavitt, BR ;
Metzler, M ;
Hackam, AS ;
Tam, J ;
Vaillancourt, JP ;
Houtzager, V ;
Rasper, DM ;
Roy, S ;
Hayden, MR ;
Nicholson, DW .
NATURE CELL BIOLOGY, 2002, 4 (02) :95-105